Endometrial cancer;Cancer de l'endomètre

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 37, Issue SUPPL. 2, 2008, Pages

  Collinet, Pierre ^a   Poncelet, Édouard ^a   Vinatier, Denis ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; K RAS PROTEIN; PROGESTERONE RECEPTOR; PROTEIN P53; TAMOXIFEN;

ARTICLE; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER INCIDENCE; COMORBIDITY; CONTRACEPTION; DIAGNOSTIC IMAGING; ECHOGRAPHY; ENDOMETRIUM CANCER; EPIDEMIOLOGICAL DATA; FRANCE; HEREDITY; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; HYSTEROSCOPY; MYOMECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; PROTEIN EXPRESSION; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ENDOMETRIUM TUMOR; FEMALE; RISK FACTOR;

CHEMOTHERAPY, ADJUVANT; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK FACTORS;

EID: 58149401856     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0368-2315(08)75574-1     Document Type: Article

References (33)

1. Sorosky J.I. Endometrial cancer. Obstet Gynecol 111 (2008) 436-447
2. Sherman M.E., Carreon J.D., Lacey Jr. J.V., and Devesa S.S. Impact of hysterectomy on endometrial carcinoma rates in the United States. J Natl Cancer Inst 97 (2005) 1700-1702
3. Chia V.M., Newcomb P.A., Trentham-Dietz A., and Hampton J.M. Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis. Int J Gynecol Cancer 17 (2007) 441-446
4. Zusterzeel P.L., Bekkers R.L., Hendriks J.C., Neesham D.N., Rome R.M., and Quinn M.A. Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer. Acta Obstet Gynecol Scand 87 (2008) 240-246
5. Soslow R.A., Bissonnette J.P., Wilton A., Ferguson S.E., Alektiar K.M., Duska L.R., et al. Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences. Am J Surg Pathol 31 (2007) 979-987
6. Pessini S.A., Zettler C.G., Wender M.C., Pellanda L.C., and Silveira G.P. Survival and prognostic factors of patients treated for Stage I to Stage III endometrial carcinoma in a reference cancer center in Southern Brazil. Eur J Gynaecol Oncol 28 (2007) 48-50
7. Shabani N., Kuhn C., Kunze S., Schulze S., Mayr D., Dian D., et al. Prognostic significance of oestrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas. Eur J Cancer 43 (2007) 2434-2444
8. Susini T., Amunni G., Molino C., Carriero C., Rapi S., Branconi F., et al. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors. Cancer 109 (2007) 882-890
9. Macdonald N.D., Salvesen H.B., Ryan A., Malatos S., Stefansson I., Iversen O.E., et al. Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based series. Int J Gynecol Cancer 14 (2004) 957-965
10. Zorn K.K., Bonome T., Gangi L., Chandramouli G.V., Awtrey C.S., Gardner G.J., et al. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Clin Cancer Res 11 (2005) 6422-6430
11. Bremond A., Bataillard A., Thomas L., Achard J.L., Fervers B., Fondrinier E., et al. Standards, Options and Recommendations 2000: non metastatic endometrial cancer. Bull Cancer 89 (2002) 697-706
12. Birinyi L., Daragó P., Török P., Csiszár P., Major T., Borsos A., et al. Predictive value of hysteroscopic examination in intrauterine abnormalities. Eur J Obstet Gynecol Reprod Biol 115 (2004) 75-79
13. Triolo O., Antico F., Palmara V., Benedetto V., Panama S., and Nicotina P.A. Hysteroscopic findings of endometrial carcinoma. Evaluation of 104 cases. Eur J Gynaecol Oncol 26 (2005) 434-436
14. Selvaggi L., Cormio G., Ceci O., Loverro G., Cazzolla A., Bettocchi S., et al. Hysteroscopy does not increase the risk of microscopic extrauterine spread in endometrial carcinoma. Int J Gynecol Cancer 13 (2003) 223-227
15. Yazbeck C., Dhainaut C., Batallan A., Benifla J.L., Thoury A., and Madelenat P. Diagnostic hysteroscopy and risk of peritoneal dissemination of tumor cells. Gynecol Obstet Fertil 33 (2005) 247-252
16. Fishman D.A., Cohen L., Blank S.V., Shulman L., Singh D., Bozorgi K., et al. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer. Am J Obstet Gynecol 192 (2005) 1214-1221 discussion 1221-2
17. Rieck G.C., Bulman J., Whitaker R., and Leeson S.C. A retrospective review of magnetic resonance imaging in assessing the extent of myometrial infiltration for patients with endometrial carcinoma. J Obstet Gynaecol 25 (2005) 765-768
18. Cabrita S., Rodrigues H., Abreu R., Martins M., Teixeira L., Marques C., et al. Magnetic resonance imaging in the preoperative staging of endometrial carcinoma. Eur J Gynaecol Oncol 29 (2008) 135-137
19. Ginath S., Menczer J., Fintsi Y., Ben-Shem E., Glezerman M., and Avinoach I. Tissue and serum CA125 expression in endometrial cancer. Int J Gynecol Cancer 12 (2002) 372-375
20. Abu-Rustum N.R., Iasonos A., Zhou Q., Oke E., Soslow R.A., Alektiar K.M., et al. Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma?. Am J Obstet Gynecol 198 (2008) 457-e1-5; discussion 457 e5-6
21. Fujimoto T., Nanjyo H., Nakamura A., Yokoyama Y., Takano T., Shoji T., et al. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer. Gynecol Oncol 107 (2007) 253-259
22. Querleu D., Leblanc E., Ferron G., Narducci F., et al. Laparoscopic surgery in gynaecological tumors. Bull Cancer 93 (2006) 783-789
23. Bats A.S., Chatellier G., Clément D., Larousserie F., Lefrère-Belda M.A., Lecuru F., et al. Comparison of different approaches in surgical management of early endometrial cancer. Bull Cancer 94 (2007) 1003-1007
24. Smith S.M., and Hoffman M.S. The role of vaginal hysterectomy in the treatment of endometrial cancer. Am J Obstet Gynecol 197 (2007) 202 e1-e6;discussion 202 e6-7
25. Occelli B., Samouelian V., Narducci F., Leblanc E., Querleu D., et al. The choice of approach in the surgical management of endometrial carcinoma: a retrospective serie of 155 cases. Bull Cancer 90 (2003) 347-355
26. Tozzi R., Malur S., Koehler C., Schneider A., et al. Laparoscopy versus laparotomy in endometrial cancer: first analysis of survival of a randomized prospective study. J Minim Invasive Gynecol 12 (2005) 130-136
27. Kalogiannidis I., Lambrechts S., Amant F., Neven P., Van Gorp T., Vergote I., et al. Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome. Am J Obstet Gynecol 196 (2007) 248-e1-8
28. Ghezzi F., Cromi A., Bergamini V., Uccella S., Beretta P., Franchi M., et al. Laparoscopic-assisted vaginal hysterectomy versus total laparoscopic hysterectomy for the management of endometrial cancer: a randomized clinical trial. J Minim Invasive Gynecol 13 (2006) 114-120
29. Lin L.L., Mutch D.G., Rader J.S., Powell M.A., and Grigsby P.W. External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer. Gynecol Oncol 106 (2007) 215-220
30. Kong A., Simera I., Collingwood M., Williams C., Kitchener H., et al., Cochrane Gynaecological Cancer Group. Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database Syst Rev 2 (2007) CD003916
31. Maggi R., Lissoni A., Spina F., Melpignano M., Zola P., Favalli G., et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer 95 (2006) 266-271
32. Narducci F., Lambaudie E., Sonoda Y., Papageorgiou T., Taïeb S., Cabaret V., et al. Endometrial cancer: what"s new ?. Gynecol Obstet Fertil 31 (2003) 581-596
33. Kew F.M., Roberts A.P., and Cruickshank D.J. The role of routine follow-up after gynecological malignancy. Int J Gynecol Cancer 15 (2005) 413-419